Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

23.45
Delayed Data
As of Jan 23
 +0.95 / +4.22%
Today’s Change
8.12
Today|||52-Week Range
23.71
+40.59%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Svoronos Dawn
Director
Buy5/23/201725,000$13.49$337.3K+73.70%
Kovacs Shane William Charles
Chief Financial Officer
Buy5/09/201710,000$10.85$108.5K+99.07%
Peltz Stuart W
Chief Executive Officer
Sale1/05/20182,230$18.03$40.2K+30.79%
Rothera Mark A
Chief Commercial Officer
Buy2/16/20173,125$10.85$33.9K+70.17%
Rothera Mark A
Chief Commercial Officer
Buy3/15/20172,966$10.85$32.2K+115.14%
Rothera Mark A
Chief Commercial Officer
Buy5/24/20172,000$10.85$21.7K+86.41%
Almstead Neil Gregory
Sale1/05/2018621$18.03$11.2K+30.79%
Utter Christine
Chief Financial Officer
Sale1/04/2018412$17.67$7.3K+30.35%
Almstead Neil Gregory
Sale1/05/201882$18.03$1.5K+30.79%
Almstead Neil Gregory
Sale1/04/201877$17.67$1.4K+30.35%
Page of 2